English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Mar 11, 2026
Study links positive views on aging to better long-term health outcomes
Patient Daily
| Mar 11, 2026
Salk scientists find key protein linking GLP-1 drug benefits to pancreatic cell health
Patient Daily
| Mar 11, 2026
How evolution within human tissues shapes disease risk and reveals new drug targets
Patient Daily
| Mar 11, 2026
Northwestern Medicine Glenview Outpatient Center expands services after multiyear project
Patient Daily
| Mar 10, 2026
Yale New Haven Hospital ranked among world’s best by Newsweek in 2026
Patient Daily
| Mar 10, 2026
Baylor College of Medicine partners with Temple ISD and Baylor Scott & White on STEM+M program
Patient Daily
| Mar 10, 2026
The Marcus Foundation awards $14.4 million to create Marcus VITAL Laboratory at Baylor College of Medicine’s Center for Aortic Surgery
Patient Daily
| Mar 10, 2026
AAFA releases 2026 Allergy Capitals report highlighting climate and health concerns
Trending
+
Pharmaceuticals
Patient Daily
| Apr 5, 2026
Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily
| Apr 7, 2026
ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
Patient Daily
| Apr 8, 2026
Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics
+
Regulatory
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
« First
«
…
28
29
30
31
32
33
34
…
»
Last »